Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration

BACKGROUND. Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker of rejection that originates from allograft cells undergoing injury. Plasma levels <1% in kidney transplant recipients have a high negative predictive value for active allograft rejection. The utility of this biomarker in ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakhani, Laila, Alasfar, Sami, Bhalla, Anshul, Aala, Amtul, Rosenberg, Avi, Ostrander, Darin, Schollenberger, Megan D., Brennan, Daniel C., Lipson, Evan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817285/
https://www.ncbi.nlm.nih.gov/pubmed/33490381
http://dx.doi.org/10.1097/TXD.0000000000001113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817285/
https://www.ncbi.nlm.nih.gov/pubmed/33490381
http://dx.doi.org/10.1097/TXD.0000000000001113

Ejemplares similares